702 related articles for article (PubMed ID: 17631128)
1. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
[TBL] [Abstract][Full Text] [Related]
2. Central adiposity and risk of Barrett's esophagus.
Edelstein ZR; Farrow DC; Bronner MP; Rosen SN; Vaughan TL
Gastroenterology; 2007 Aug; 133(2):403-11. PubMed ID: 17681161
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):745-52. PubMed ID: 12163328
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.
Almers LM; Graham JE; Havel PJ; Corley DA
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2256-64.e1-3. PubMed ID: 25632808
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus.
Thomas SJ; Almers L; Schneider J; Graham JE; Havel PJ; Corley DA
Dig Dis Sci; 2016 Jan; 61(1):70-9. PubMed ID: 26396004
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus and medications that relax the lower esophageal sphincter.
Corley DA; Levin TR; Habel LA; Buffler PA
Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
[TBL] [Abstract][Full Text] [Related]
7. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
[TBL] [Abstract][Full Text] [Related]
8. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.
Eisen GM; Sandler RS; Murray S; Gottfried M
Am J Gastroenterol; 1997 Jan; 92(1):27-31. PubMed ID: 8995932
[TBL] [Abstract][Full Text] [Related]
9. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
10. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
11. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population.
Kang MS; Park DI; Oh SY; Yoo TW; Ryu SH; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
J Gastroenterol Hepatol; 2007 Oct; 22(10):1656-61. PubMed ID: 17845694
[TBL] [Abstract][Full Text] [Related]
12. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
El-Serag HB; Graham DY; Satia JA; Rabeneck L
Am J Gastroenterol; 2005 Jun; 100(6):1243-50. PubMed ID: 15929752
[TBL] [Abstract][Full Text] [Related]
13. Barrett's esophagus and obesity: the missing part of the puzzle.
Moayyedi P
Am J Gastroenterol; 2008 Feb; 103(2):301-3. PubMed ID: 18289199
[TBL] [Abstract][Full Text] [Related]
14. Current and past smoking significantly increase risk for Barrett's esophagus.
Smith KJ; O'Brien SM; Green AC; Webb PM; Whiteman DC;
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):840-8. PubMed ID: 19410015
[TBL] [Abstract][Full Text] [Related]
15. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
[TBL] [Abstract][Full Text] [Related]
17. Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease?
Gerson LB; Ullah N; Fass R; Green C; Shetler K; Singh G
Aliment Pharmacol Ther; 2007 May; 25(9):1079-86. PubMed ID: 17439509
[TBL] [Abstract][Full Text] [Related]
18. Visceral obesity and the risk of Barrett's esophagus.
Akiyama T; Yoneda M; Maeda S; Nakajima A; Koyama S; Inamori M
Digestion; 2011; 83(3):142-5. PubMed ID: 21266807
[TBL] [Abstract][Full Text] [Related]
19. Association between GERD-related erosive esophagitis and obesity.
Lee HL; Eun CS; Lee OY; Jeon YC; Sohn JH; Han DS; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH
J Clin Gastroenterol; 2008 Jul; 42(6):672-5. PubMed ID: 18360294
[TBL] [Abstract][Full Text] [Related]
20. Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.
Mokrowiecka A; Daniel P; Jasinska A; Pietruczuk M; Pawlowski M; Szczesniak P; Orszulak-Michalak D; Malecka-Panas E
Hepatogastroenterology; 2012; 59(120):2395-9. PubMed ID: 22944288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
